Rekvina Labs

23
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE092O01028
  • NSEID:
  • BSEID: 526075
INR
7.43
0.35 (4.94%)
BSENSE

Jan 14

BSE+NSE Vol: 250

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Rekvina Labs Cash flow Statement
Figures in Cr
Standaloned Cash Flow Results
Mar'18
Mar'17
Mar'16
Mar'15
Mar'14
Mar'13
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Rekvina Labs
Markets Mojo
Figures in Cr
standaloned Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
-798425.26
5030.57
-8,03,455.00
-15971.47%
Adjustment
262.26
1684.58
-1,422.00
-84.43%
Changes In working Capital
567431.1
-2381.07
5,69,812.00
23930.93%
Cash Flow after changes in Working Capital
-230731.9
4334.08
-2,35,065.00
-5423.66%
Cash Flow from Operating Activities
-230731.9
4198.77
-2,34,929.00
-5595.23%
Cash Flow from Investing Activities
0
-202.03
202.00
100.00%
Cash Flow from Financing Activities
364807.74
-3831.18
3,68,638.00
9622.07%
Net Cash Inflow / Outflow
134075.84
165.56
1,33,910.00
80883.23%
Opening Cash & Cash Equivalents
1337138
326.46
13,36,812.00
409487.09%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
1471213.84
492.02
14,70,721.00
298915.05%
Cash Flow - Snapshot (Standalone) - Mar'18
stock-summary

YoY Growth in year ended Mar 2018 is -329.27% vs 122.94% in Mar 2017

Mar'18
Mar'17
Change(%)
Cash Flow from Operating Activities
-0.02
0.01
-329.27%